idsa : infectious diseases society of america topicsabcdefghijklmnopqrstuvwxyz contact us | about idsa | membership | member networking | find a member log in | register topics of interestantimicrobial resistancebioterrorismemerging infectionsglobal idhepatitis chivimmunizationinfluenzalyme diseasemanage your practicephysician paymentsbilling & codingquality improvementvalue of id specialistshealth information technologymedicare & your practicepractice management listserveguidelines/patient careidsa practice guidelinesguideline methodology and other resourcesfor patients & publicemerging clinical issuescareers & trainingid/hiv career centerstudent & resident opportunitiesfellows-in-training centerprogram director resourcescontinuing medical educationmaintenance of certificationonline courses & examsresearch & funding opportunitiesinternational hiv training opportunitiespolicy & advocacyaccess & reimbursementantimicrobial resistanceinfection prevention & controlhiv/aids & global tbimmunizations & vaccinesemerging infections & biothreatsresearch & infrastructureworkforce & trainingfederal fundingdiagnosticsnews & publicationsclinical infectious diseasesjournal of infectious diseasesopen forum infectious diseasesidsa newshivma enewsscience speaks blognews releases from idsanews from the journalsfor mediameetingsidweek 2014idweek 2013about idweek cmepast meetingsid-related meetings calendarannual meeting abstract archives view menuguidelinesa-z index topics of interestantimicrobial resistancebioterrorismemerging infectionsglobal idhepatitis chivimmunizationinfluenzalyme diseasemanage your practicephysician paymentsbilling & codingquality improvementvalue of id specialistshealth information technologymedicare & your practicepractice management listserveguidelines/patient careidsa practice guidelinesguideline methodology and other resourcesfor patients & publicemerging clinical issuescareers & trainingid/hiv career centerstudent & resident opportunitiesfellows-in-training centerprogram director resourcescontinuing medical educationmaintenance of certificationonline courses & examsresearch & funding opportunitiesinternational hiv training opportunitiespolicy & advocacyaccess & reimbursementantimicrobial resistanceinfection prevention & controlhiv/aids & global tbimmunizations & vaccinesemerging infections & biothreatsresearch & infrastructureworkforce & trainingfederal fundingdiagnosticsnews & publicationsclinical infectious diseasesjournal of infectious diseasesopen forum infectious diseasesidsa newshivma enewsscience speaks blognews releases from idsanews from the journalsfor mediameetingsidweek 2014idweek 2013about idweek cmepast meetingsid-related meetings calendarannual meeting abstract archives idweeka joint meeting of idsa, hivma, pids, sheaidweek homeclaim cme/cpedigital libraryinteractive programidweek articles from ofidhepatitis c virusupdates on a rapidly changing fieldhcvguidelines.orgwebsite press releasemoc module on hcvmembers-only webinarsmore hcv resources from idsaebola virusidsa on involuntary quarantinecdc tightens ppe guidanceguidance for id clinicianscdc: patient evaluationshea ebola resourcesebola articles from cid, jidclinical guidance from idweekeducation research foundationidsa foundation launches new sitefeatured programsprogramsabout the foundationdonorsdonate today!bad bugs need drugshelp idsa’s advocacy effortsurge congress to pass adaptidsa comments to pcast (pdf)idsa supports fda pathwayantibioticsnow.orgbetter tests for better caremore informationthe value of the id specialistcid studypress releaseaudio releasesvalue of id toolkitmrsa prompts guidelines updateskin and soft tissue infectionsnew guideline in cidpress releaseguideline resourcesrenew your membership todaylog into myidsaadult immunizationsnew standards from nvacnew nvac standardsidsa immunization principlesawards deadlineslaunch a career; recognize colleaguesresearch awards: mar. 17society awards: apr. 1better tests, better careidsa policy report on diagnosticsnew cid supplementpress releaseinfographic: patient impactlab guide to using testsworld aids day, dec. 1get involvedwe can beat hivhope act becomes law health law is good news! new idsa journalopen forum infectious diseasespress release on editor more on ofidantibiotic development10 x '20 initiative updatereport in cidpress releaseantibioticsnow.orgidsa policyidsa journals appfor ios deviceslearn moredownload the appimmunizationidsa policystrengthening u.s. effortshealth care workersmore informationworld hepatitis day7/28/2013cid/jid articlescid: hcv for drug injectorsidsa's hcv resourcesaasld/idsa collaborationidsa education resourcesnew: id board practice examnew moc modulesupdated lyme disease courseinfection control courseidsa 50th anniversarycelebrate with us!50th anniversary homewatch the videosphoto galleriesshare your memoriesseasonal influenzaresourceswhat's true about fluidsa guideline in cididsa policyprinciples for u.s. actionhcw vaccinationfungal meningitis outbreaksituation updatelatest clinical guidancenational influenza vaccination weekcdc resourcesvaccine recommendationsmore on nivwidsa policyhcw vaccinationget smart about antibiotics weekresources from cdc idsaget smart websiterelated cid and jid articlesconsensus statement (pdf)blog post: dr. david relmanidsa's 10x'20 initiativeliterature alertssign up nowjournal of infectious diseasesclinical infectious diseasesjournal of pidsupdated idsa principlespandemic and seasonal influenzaprinciples for u.s. actionpolicy forum webcastlyme diseaselyme resourceslyme disease: ten factscdc resourcesupdated lyme disease courseidsa guidelinelyme disease guidelinenational immunization awareness monthcid and jid articlesnnii website aap resourcesidsa policyidsa and hivma advocacy centerhivma on supreme court rulingtake action today! spur antibiotic rdstop cuts in id fundingsupport hiv fundinghepatitis resourcescid and jid articlescdc resourcesrelated guidelineshepatitis bhepatitis c upcoming meetingsalert menovember 4, 2014 | des plaines, illinois2014 fall meeting and 67th pasteur award presentationdecember 12 - 13, 2014 | paris, france4th hcv advances meeting 2014april 25 - 28, 2015 | copenhagen, denmark25th eccmid 2015see full calendar find practice guidelines alert me find practice guidelinesselectantimicrobial agent useinfections by organ systeminfections by organismother guidelinesalso available:for mobilepocketcards the infectious diseases society of america (idsa) represents physicians, scientists and other health care professionals who specialize in infectious diseases. idsa’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. alert mepolicy newsidsa president provides testimony on the need for new antibioticson september 19th,idsa president barbara murray provided testimony to the health subcommittee ofthe house energy commerce committee on the need for a coordinated federalstrategy to spur research and development for new antibiotics.  tell congress #cutshurt!your help is needed to send a strong message to congress that federal agency and program funding levels need to be finalized in the weeks ahead, so that new cuts are not set into motion. take three minutes to support antibiotic developmenturge congress to help speed patient access to the most urgently needed new antibacterial drugs.idsa members call on congress to advance lpad pathwayidsa members answered a request from the house energy and commerce committee on proposals to spur drug research and development.4/10/2014staar actthe staar act was reintroduced by sen. sherrod brown this week. the bill, championed by idsa, provides stronger federal leadership to coordinate activities that address resistance and strengthen accountability.idsa applauds president’s commitment to combatting antibiotic resistance in fy 2015 budget, dismayed by related reductionspresident obama’s fiscal year 2015 budget includes a request to more than double funding for the cdc to combat antibiotic resistance, in addition to requests to fund efforts to track, prevent and control antibiotic resistance in the u.s. and around the world.1/31/2014idsa applauds state of the union pledge on drug resistancethe society reiterated its support for the antibiotic development to advance patient treatment act and the strategies to address antimicrobial resistance act.12/12/2013adapt act introduced to establish new drug approval pathwayidsa applauds the bipartisan introduction of legislation to establish a new limited-population antibacterial and antifungal drug approval pathway.1 of 8 alert mebreaking news and alerts 10/31/2014 3:02:14 pm cdc releases two new clinical resources in the fight against ebola – ppe demonstration video, ebola clinical slide set cdc alert 10/29/2014 4:58:55 pm cdc releases new guidance for er evaluation and management for patients presenting with possible evd cdc ebola alert 10/29/2014 2:41:49 pm first vaccine approved by fda to prevent serogroup b meningococcal disease fda alert 10/28/2014 9:38:01 am revised interim guidance for monitoring and movement of persons with potential ev exposure cdc ebola alert 1 of 3 alert menews from idsa and the journalsidsa statement on involuntary quarantine of healthcare workers returning from ebola-affected countries read more“breath test” shows promise for diagnosing fungal pneumonia read moreanalyzing a patient’s breath for key compoundsmay help detect invasive aspergillosis, a new cid study finds.idsa applauds white house action and house committee’s leadership on antibiotic resistance read moreidsa president, dr. barbara murray testifies before thehouse energy commerce committee on the urgency of fighting antimicrobialresistance. guideline for the management of chronic kidney disease in patients infected with hiv read morehiv patients who have, or who are at risk for kidney disease benefit from antiretroviral therapy, suggest updated guidelines published by the hiv medicine association of the infectious diseases society of america (idsa).antiretroviral therapy (art) is beneficial for the 5 to 10 percent of hiv-infected patients with reduced kidney function, although tenofovir – the most widely prescribed medication – should be avoided, recommend updated guidelines released by the hiv medicine association (hivma) of the infectious diseases society of america (idsa) and published in the journal clinical infectious diseases - see more at: therapy (art) is beneficial for the 5 to 10 percent of hiv-infected patients with reduced kidney function, although tenofovir – the most widely prescribed medication – should be avoided, recommend updated guidelines released by the hiv medicine association (hivma) of the infectious diseases society of america (idsa) and published in the journal clinical infectious diseases - see more at: news: september 2014 read morein this issue:president's messageidsa provides ebola resourcescountdown to idweek 2014idsa journal clubidsa, hivma call for state medicaid programs to lift hcv provider restrictions read moreidsa and hivma urge the centers for medicare and medicaid services (cms) to carefully review all state restrictions on the new hcv treatment to ensure they are evidenced-based and to bar states from excluding id and hiv physicians from prescribing the new hcv treatments. (09/08/2014)idsa education and research foundation read morethe idsa education and research foundation has launched abrand new website to highlight its initiatives. the idsa education and researchfoundation has supported the careers of medical students, fellows, and idspecialists since 2001. 1 of 7 infectious diseases society of america1300 wilson boulevard suite 300 arlington, va 22209 | phone: (703) 299-0200 | fax: (703) 299-0204for mediafor patients publicpartners © copyright idsa 2014 | sitemap | terms of use | privacy | hivma | contact us © copyright idsa 2014 infectious diseases society of americafull site mobile site   